14th International Stereotactic Radiosurgery Society (ISRS) is the most authoritative academic conference in the field of international radiopharmaceuticals. The 23rd ISRS was held at the Beijing International Convention Center on 26 May to 31 May.
The ISRS2019 Nuclear Medicine Summit, hosted by Hui Jia Biotech (China) Co., Ltd.,.Ouija took the ISRS meeting as an opportunity and invited many well-known experts and scholars in nuclear medicinearea local and overseas to give lectures on radiopharmaceuticals and nuclear medicine. The most cutting-edge technology in the field of nuclear medicine explores the future development of the industry. The forum was held at the Wuzhou Crown International Hotel in Beijing. The conference aims to promote exchanges and cooperation between colleagues in the industry and aims to help the rapid development of nuclear medicine in China.
The forum was opened by Professor Wang Fan. He is the Chairman of the Chinese Biophysical Molecular Imaging Professional Committee. He also made a special report for everyone. She said that the organization of such forums in China will more effectively promote the research and development of nuclear medicine and radiopharmaceuticals in China.
Professor Wang Fan, Chairman of the Chinese Biophysical Molecular Imaging Professional Committee, delivered the opening speech
Professor Wang Fan’s speech received warm applause from the guests. Afterwards, the forum specially arranged domestic and foreign experts to give special lectures. Professor Chen Xiaoyuan from the National Institutes of Health (NIH), Professor Cheng Zhen from Stanford University, Gábor NÉMETH from Mediiso Molecular Imaging Department, Dr. Zhu Zhaohui from the Nuclear Medicine Department of Peking Union Medical College Hospital and Zhang Yingjian from the Cancer Hospital of Fudan University. The 11 experts shared the most cutting-edge achievements and findings of the nuclear medicine in the world.
Nuclear Imaging Guided Combined Targeted Radiotherapy and anti-PD-L1 Immunotherapy
Translating Small Molecule Probes into Preliminary Clinical Applications
Update On High-End Solutions For Translational Imaging
68Ga/177Lu A Preliminary Study on the Application of Labeled Compounds in the Precise Diagnosis and Treatment of Tumors 68Ga/177Lu
Performance and Applications of Small Animal SPECT/CT
Peptide-based nuclear probes for tumor diagnosis
Boramino acid as a synergistic agent for probing and perturbing
Image-guided glioma surgery by intraoperatively digitaliting tumor metabolic margins
Dynamic PET Imaging and Quantification
Radioiodinated Nanomaterials and Macromolecular Probes for Tumor Theranostics
Looking forward to meeting again
This forum is one of the important activities of 2019 ISRS. Mr. Zhang Yang, President of Huijia Bio, said: The success of the forum is very positive and important. It provides us with an opportunity to exchange and study with top international experts. Hui Jia is more willing to contribute to the improvement of research in the field of nuclear medicine in China by building this platform. At the same time, from all efforts of us, we will form a regular long-term mechanism to make the forum more refined and reach a new height. I look forward to meeting next time.
Source: 热烈庆祝 | ISRS 2019核医学高峰论坛圆满结束
Shedding light on cancer metabolism in real-t...
Point-of-care Ratiometric Fluorescence Imagin...
The Adipocyte Na/K-ATPase Oxidant Amplificati...
Congratulations！ | ISRS 2019 Nuclear Medicine...
VDAC2 enables BAX to mediate apoptosis and li...
Body fat distribution on computed tomography ...
A Deep-learning Model May Help Predict Lung C...
Physical inactivity tied to dementia in cardi...
Unitedwell 2018 New Year Sales Conference was...
The 1st Announcement of the Summit on Space R...
Unitedwell congratulates The Second Annual Co...
Unitedwellwarmly celebrated the grand opening...